Bain Capital Life Sciences Investors, LLC Olema Pharmaceuticals, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $312 Million
- Q3 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 6,843,954 shares of OLMA stock, worth $59.5 Million. This represents 21.2% of its overall portfolio holdings.
Number of Shares
6,843,954
Previous 6,843,954
-0.0%
Holding current value
$59.5 Million
Previous $29.2 Million
126.53%
% of portfolio
21.2%
Previous 8.75%
Shares
2 transactions
Others Institutions Holding OLMA
# of Institutions
134Shares Held
65.9MCall Options Held
379KPut Options Held
13K-
Paradigm Biocapital Advisors LP New York, NY6.79MShares$59 Million2.11% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$46 Million2.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$34.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$31.2 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.47MShares$30.2 Million1.06% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $351M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...